214 related articles for article (PubMed ID: 25017008)
1. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease.
Lee EK; Lee SY; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):359-68. PubMed ID: 25017008
[TBL] [Abstract][Full Text] [Related]
2. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
Inomata H; Rao NA
Am J Ophthalmol; 2001 May; 131(5):607-14. PubMed ID: 11336935
[TBL] [Abstract][Full Text] [Related]
3. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Park UC; Cho IH; Lee EK; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
[TBL] [Abstract][Full Text] [Related]
4. Chronic Recurrent Vogt-Koyanagi-Harada Disease and Development of 'Sunset Glow Fundus' Predict Worse Retinal Sensitivity.
Abu El-Asrar AM; Al Mudhaiyan T; Al Najashi AA; Hemachandran S; Hariz R; Mousa A; Al-Muammar A
Ocul Immunol Inflamm; 2017 Aug; 25(4):475-485. PubMed ID: 27003480
[TBL] [Abstract][Full Text] [Related]
5. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of "sunset glow" fundus in Vogt-Koyanagi-Harada disease.
Suzuki S
Jpn J Ophthalmol; 1999; 43(4):327-33. PubMed ID: 10482481
[TBL] [Abstract][Full Text] [Related]
7. Choroidal thickness in convalescent vogt-koyanagi-harada disease.
Takahashi H; Takase H; Ishizuka A; Miyanaga M; Kawaguchi T; Ohno-Matsui K; Mochizuki M
Retina; 2014 Apr; 34(4):775-80. PubMed ID: 23979311
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
9. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids.
Hirooka K; Saito W; Namba K; Mizuuchi K; Iwata D; Hashimoto Y; Ishida S
PLoS One; 2017; 12(2):e0172612. PubMed ID: 28241069
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease.
Feng H; Chen W; Yang J; Kong H; Li H; He Y; Wang H
BMC Ophthalmol; 2024 Jun; 24(1):238. PubMed ID: 38849758
[TBL] [Abstract][Full Text] [Related]
11. Predictive Biomarker for Progression Into the Sunset Glow Fundus of Vogt-Koyanagi-Harada Disease, Using Adaptive Binarization of Fundus Photographs.
Komuku Y; Ishikawa H; Ide A; Matsuoka T; Fukuyama H; Okadome T; Gomi F
Transl Vis Sci Technol; 2020 Oct; 9(11):10. PubMed ID: 33133773
[TBL] [Abstract][Full Text] [Related]
12. Polarization-Sensitive Optical Coherence Tomographic Documentation of Choroidal Melanin Loss in Chronic Vogt-Koyanagi-Harada Disease.
Miura M; Makita S; Yasuno Y; Tsukahara R; Usui Y; Rao NA; Ikuno Y; Uematsu S; Agawa T; Iwasaki T; Goto H
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4467-4476. PubMed ID: 28863408
[TBL] [Abstract][Full Text] [Related]
13. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
Nakai K; Gomi F; Ikuno Y; Yasuno Y; Nouchi T; Ohguro N; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1089-95. PubMed ID: 22240936
[TBL] [Abstract][Full Text] [Related]
14. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
Nakayama M; Keino H; Watanabe T; Okada AA
Br J Ophthalmol; 2019 Feb; 103(2):274-278. PubMed ID: 29666121
[TBL] [Abstract][Full Text] [Related]
16. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation.
Keino H; Goto H; Usui M
Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):878-82. PubMed ID: 12397437
[TBL] [Abstract][Full Text] [Related]
17. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between Hyperreflective Foci in the Choroid and Choroidal Discoloration in Vogt-Koyanagi-Harada Disease.
Kim YH; Togloom A; Oh J
Invest Ophthalmol Vis Sci; 2022 Aug; 63(9):27. PubMed ID: 36006654
[TBL] [Abstract][Full Text] [Related]
19. A Novel Risk Stratification-Based Immunomodulatory Treatment Strategy for Vogt-Koyanagi-Harada Disease.
Jin K; Liang A; Song H; Xiao F; Gao F; Han X; Zhang M; Zhao C
Am J Ophthalmol; 2024 Jun; 262():25-33. PubMed ID: 38369223
[TBL] [Abstract][Full Text] [Related]
20. Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings.
Vasconcelos-Santos DV; Sohn EH; Sadda S; Rao NA
Retina; 2010 Jan; 30(1):33-41. PubMed ID: 20010321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
